methamphetamine has been researched along with ginsenoside re in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jang, CG; Kim, HC; Ko, SK; Nabeshima, T; Nah, SY; Nguyen, TT; Park, DH; Shin, EJ; Shin, SW; Wie, MB; Yang, BW | 1 |
| Jang, CG; Jeong, JH; Kim, HC; Ko, SK; Nah, SY; Nam, Y; Nguyen, TT; Shin, EJ; Wie, MB | 1 |
| Bing, G; Byun, JK; Dang, DK; Hong, JS; Jang, CG; Jeong, JH; Kim, DJ; Kim, HC; Ko, SK; Nah, SY; Shin, EJ; Tran, HQ | 1 |
| Byun, JK; Dang, DK; Jeong, JH; Jin, D; Kim, HC; Ko, SK; Nah, SY; Nguyen, YND; Park, JH; Sharma, N; Shin, EJ; Tran, HP; Tran, NKC; Xiaoyan, Z | 1 |
4 other study(ies) available for methamphetamine and ginsenoside re
| Article | Year |
|---|---|
Ginsenoside Re rescues methamphetamine-induced oxidative damage, mitochondrial dysfunction, microglial activation, and dopaminergic degeneration by inhibiting the protein kinase Cδ gene.
Topics: Animals; Dopaminergic Neurons; Ginsenosides; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microglia; Mitochondria; Nerve Degeneration; Oxidative Stress; Protein Kinase C-delta; Protein Kinase Inhibitors | 2014 |
Ginsenoside Re protects methamphetamine-induced mitochondrial burdens and proapoptosis via genetic inhibition of protein kinase C δ in human neuroblastoma dopaminergic SH-SY5Y cell lines.
Topics: Antioxidants; Apoptosis Regulatory Proteins; Cell Line, Tumor; Central Nervous System Stimulants; Cytochromes c; Cytosol; Dopaminergic Neurons; Ginsenosides; Humans; Membrane Potential, Mitochondrial; Methamphetamine; Mitochondria; Neuroprotective Agents; Protein Kinase C-delta; Tyrosine 3-Monooxygenase | 2015 |
Ginsenoside Re protects methamphetamine-induced dopaminergic neurotoxicity in mice via upregulation of dynorphin-mediated κ-opioid receptor and downregulation of substance P-mediated neurokinin 1 receptor.
Topics: Animals; Dopamine; Dopaminergic Neurons; Dynorphins; Ginsenosides; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Knockout; Neurokinin-1 Receptor Antagonists; Piperidines; Reactive Oxygen Species; Receptors, Neurokinin-1; Receptors, Opioid, kappa; Substance P; Up-Regulation | 2018 |
Ginsenoside Re blocks Bay k-8644-induced neurotoxicity via attenuating mitochondrial dysfunction and PKCδ activation in the hippocampus of mice: Involvement of antioxidant potential.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Antioxidants; Bays; Ginsenosides; Hippocampus; Methamphetamine; Mice; Mice, Knockout; Mitochondria; Seizures | 2023 |